Surgery after treatment with imatinib and/or sunitinib in patients with metastasized gastrointestinal stromal tumors: is it worthwhile?

BACKGROUND: Standard treatment for metastatic gastrointestinal stromal tumors (GISTs) is systemic therapy with imatinib. Surgery is performed to remove metastatic lesions to induce long-term remission or even curation. In other patients, surgery is performed to remove (focal) progressive or symptoma...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tielen, Ronald, Verhoef, Cornelis, van Coevorden, Frits, Gelderblom, Hans, Sleijfer, Stefan, Hartgrink, Henk H, Bonenkamp, Johannes J, van der Graaf, Winette T, de Wilt, Johannes H W
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2012
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3422188/
https://ncbi.nlm.nih.gov/pubmed/22703877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-10-111
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki